KabaFusion Selected by UCB as a Limited Distribution Partner for RYSTIGGO® (rozanolixizumab-noli) CERRITOS, Calif. and LEXINGTON, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected by UCB as a limited distribution partner to...